132 related articles for article (PubMed ID: 18811723)
1. [18F]FDG PET/CT in pancreatic neuroendocrine tumours associated with von Hippel Lindau Syndrome.
Kok J; Lin M; Wong V; Campbell P; Lin P
Clin Endocrinol (Oxf); 2009 Apr; 70(4):657-9. PubMed ID: 18811723
[No Abstract] [Full Text] [Related]
2. Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions.
Sadowski SM; Weisbrod AB; Ellis R; Patel D; Alimchandani M; Quezado M; Millo C; Venzon DJ; Nilubol N; Linehan WM; Kebebew E
J Am Coll Surg; 2014 May; 218(5):997-1003. PubMed ID: 24661849
[TBL] [Abstract][Full Text] [Related]
3. [Gastroenterological manifestations of von Hippel-Lindau disease - a case report].
Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
Pol Merkur Lekarski; 2017 Aug; 43(254):66-68. PubMed ID: 28875972
[TBL] [Abstract][Full Text] [Related]
4.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract][Full Text] [Related]
5. Radiopathological correlation of a von Hippel-Lindau syndrome associated pancreatic neuroendocrine tumour with clear cell features.
Hopp AC; Collins JM; Nguyen CC; Yang M
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30709893
[No Abstract] [Full Text] [Related]
6. FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
Kulkarni M; Purandare N; Zade A; Agrawal A; Shah S; Rangarajan V
Clin Nucl Med; 2013 Jul; 38(7):e302-3. PubMed ID: 23486326
[TBL] [Abstract][Full Text] [Related]
7. Potential value of EUS in pancreatic surveillance of VHL patients.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP
Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatic tumor: unusual onset of Von-Hippel Lindau syndrome].
Garberini A; Caricato M; Valeri S; Alloni R; Ausania F; Rosignoli A; Greco S; Rabitti C; Coppola R
Suppl Tumori; 2005; 4(3):S56. PubMed ID: 16437901
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Weisbrod AB; Kitano M; Gesuwan K; Millo C; Herscovitch P; Nilubol N; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2012 Apr; 97(4):E613-7. PubMed ID: 22259055
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
Kitano M; Millo C; Rahbari R; Herscovitch P; Gesuwan K; Webb RC; Venkatesan AM; Phan GQ; Hughes MS; Libutti SK; Nilubol N; Linehan WM; Kebebew E
Surgery; 2011 Dec; 150(6):1122-8. PubMed ID: 22136831
[TBL] [Abstract][Full Text] [Related]
11. Paediatric pancreatic neuroendocrine tumours in von Hippel-Lindau disease.
O'Toole SM; Sahdev A; Bhattacharya S; Feakins R; Gevers EF; Drake WM
Endocr Relat Cancer; 2018 Sep; 25(9):L43-L47. PubMed ID: 29752349
[No Abstract] [Full Text] [Related]
12. Hepatobiliary and Pancreatic: Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease.
Yamashima M; Ozawa E; Ohnita K; Tabata K; Natsuda K; Ono S; Hidaka M; Eguchi S; Nakao K
J Gastroenterol Hepatol; 2018 Nov; 33(11):1821. PubMed ID: 29888404
[No Abstract] [Full Text] [Related]
13. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
[TBL] [Abstract][Full Text] [Related]
14. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
Marcos HB; Libutti SK; Alexander HR; Lubensky IA; Bartlett DL; Walther MM; Linehan WM; Glenn GM; Choyke PL
Radiology; 2002 Dec; 225(3):751-8. PubMed ID: 12461257
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic mixed serous neuroendocrine neoplasm with clear cells leading to diagnosis of von Hippel Lindau disease.
Kakkar A; Sharma MC; Yadav R; Panwar R; Mathur SR; Iyer VK; Sahni P
Pathol Res Pract; 2016 Aug; 212(8):747-50. PubMed ID: 27161305
[TBL] [Abstract][Full Text] [Related]
17. Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Hou G; Cheng X; Chi Y; Wang X; Zheng R
Clin Nucl Med; 2024 Mar; 49(3):289-291. PubMed ID: 38306383
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.
Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T
World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520
[TBL] [Abstract][Full Text] [Related]
19. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.
Weisbrod AB; Kitano M; Thomas F; Williams D; Gulati N; Gesuwan K; Liu Y; Venzon D; Turkbey I; Choyke P; Yao J; Libutti SK; Nilubol N; Linehan WM; Kebebew E
J Am Coll Surg; 2014 Feb; 218(2):163-9. PubMed ID: 24440063
[TBL] [Abstract][Full Text] [Related]
20. 68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Banezhad F; Kiamanesh Z; Emami F; Sadeghi R
Clin Nucl Med; 2019 Jun; 44(6):e385-e387. PubMed ID: 30985433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
